Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis

BACKGROUND: Systemic juvenile idiopathic arthritis (SoJIA) is the most striking form of juvenile idiopathic arthritis. The aim of our study was to evaluate the clinical responses and outcomes of children with SoJIA to IL-6 blockade using two different tocilizumab (TCZ) treatment protocols designed f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Rheumatol Online J
Main Authors: Kostik, Mikhail M, Dubko, Margarita F, Masalova, Vera V, Snegireva, Ludmila S, Kornishina, Tatyana L, Chikova, Irina A, Isupova, Eugenia A, Kuchinskaya, Ekaterina M, Glebova, Natalia I, Buchinskaya, Natalia V, Kalashnikova, Olga V, Chasnyk, Vyacheslav G
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4328569/
https://ncbi.nlm.nih.gov/pubmed/25685108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-13-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados